Hello and Welcome to Patientsville.com, Your Source for all TELZIR information. We are dedicated to provide You with TELZIR safety information. Learn about TELZIR serious adverse events reported to Food and Drug Administration (FDA).

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Health Expert

Do You Have a Question about Your Health?

We will help You understand Your condition and Feel better! Ask Our Health Experts!

Private, Confidential and Discreet

TELZIR Safety Reports

Total TELZIR reports: 39.
TELZIR FDA safety alerts: No.
Reported deaths: 2    Reported hospitalizations: 28.
Take TELZIR Side Effects Survey or Share Your TELZIR Story. Read More Here.

Consumer or non-health professional from FRANCE reported TELZIR problem on Dec 20, 2006. Female patient, 37 years of age, weighting 112.4 lb, was diagnosed with tuberculosis and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: agitation, blood creatine phosphokinase increased, cognitive disorder, confusional state, neuroleptic malignant syndrome, pyrexia, rhabdomyolysis, transaminases increased. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with NORVIR, RIMIFON, LARGACTIL, KALETRA, TERCIAN. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Consumer or non-health professional from FRANCE on Jan 15, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: angioedema, lip oedema. TELZIR dosage: unknown. During the same period patient was treated with COMBIVIR, NORVIR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported TELZIR problem on Feb 07, 2007. Female patient, 35 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, cheilitis, chest discomfort, conjunctivitis, erythema multiforme, gastrointestinal disorder, hypotension, pyrexia. TELZIR dosage: 1400MG PER DAY. During the same period patient was treated with KIVEXA, NORVIR, BACTRIM, ADVIL, TRIFLUCAN. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Consumer or non-health professional from FRANCE on Feb 09, 2007. Female patient, 44 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: prurigo. TELZIR dosage: unknown. During the same period patient was treated with KIVEXA, INVIRASE, NORVIR. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported TELZIR problem on Feb 23, 2007. Male patient, 55 years of age, weighting 187.4 lb, was diagnosed with hiv infection cdc category b3 and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: bradyphrenia, depression, disturbance in attention. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with NORVIR, VIREAD, VIDEX, SAROTEN. Patient recovered.

TELZIR problem was reported by a Physician from GERMANY on Mar 14, 2007. Male patient, 35 years of age, weighting 165.3 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: autoimmune thyroiditis, diarrhoea, hypothyroidism, thyroid function test abnormal. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with TRUVADA. Patient recovered.

Physician from FRANCE reported TELZIR problem on Mar 26, 2007. Male patient, 45 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: haemolysis, haemorrhage. TELZIR dosage: unknown. During the same period patient was treated with COMBIVIR, RITONAVIR. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Consumer or non-health professional from FRANCE on Apr 12, 2007. Female patient, 35 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, cheilitis, chest discomfort, conjunctivitis, dermatitis exfoliative, erythema, erythema multiforme, gastrointestinal disorder, hyperkeratosis. TELZIR dosage: 1400MG PER DAY. During the same period patient was treated with KIVEXA, NORVIR, BACTRIM, ADVIL, TRIFLUCAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported TELZIR problem on Apr 25, 2007. Female patient, 39 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, pancytopenia, serum ferritin increased. TELZIR dosage: unknown. During the same period patient was treated with BACTRIM, SPECIAFOLDINE, KALETRA. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Physician from FRANCE on June 04, 2007. Male patient, 46 years of age, weighting 123.5 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with COMBIVIR, NORVIR, PEGYLATED INTERFERON ALPHA, NOVONORM, SPECIAFOLDINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported TELZIR problem on June 15, 2007. Male patient, 49 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: blood amylase increased, blood lactate dehydrogenase increased, cholestasis, gamma-glutamyltransferase increased, hypercholesterolaemia, hypertriglyceridaemia, lipase increased, pancreatitis acute, transaminases increased. TELZIR dosage: unknown. During the same period patient was treated with NORVIR, TRUVADA. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Physician from ITALY on May 02, 2006. Male patient, 33 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia. TELZIR dosage: 1400MG PER DAY. During the same period patient was treated with RITONAVIR, STAVUDINE, TENOFOVIR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported TELZIR problem on May 16, 2006. Male patient, 43 years of age, weighting 156.5 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: conjunctival hyperaemia, hepatocellular damage, pruritus, pyrexia, rash, rash maculo-papular. TELZIR dosage: unknown. During the same period patient was treated with EMTRIVA, RETROVIR, NORVIR. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Consumer or non-health professional from FRANCE on July 25, 2006. Female patient, 56 years of age, weighting 85.98 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: anaemia, autoimmune thrombocytopenia. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with KIVEXA, NORVIR, BACTRIM DS. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported TELZIR problem on Aug 01, 2006. Female patient, 43 years of age, weighting 125.7 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, fatigue, hyperhidrosis, hypersensitivity, malaise, nausea, rash, vomiting. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with KIVEXA, TRUVADA, NORVIR. Patient recovered.

TELZIR problem was reported by a Physician from GERMANY on July 19, 2006. Male patient, 39 years of age, weighting 172.0 lb, was diagnosed with hiv infection, epilepsy, depression, tachycardia and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: anaemia. TELZIR dosage: unknown. During the same period patient was treated with COMBIVIR, VALPROATE, AMITRIPTYLIN, METOPROLOL TARTRATE. Patient recovered.

Consumer or non-health professional from FRANCE reported TELZIR problem on July 25, 2006. Female patient, 56 years of age, weighting 85.98 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: anaemia, autoimmune thrombocytopenia. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with KIVEXA, NORVIR, BACTRIM DS. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Health Professional from GERMANY on Aug 11, 2006. Male patient, 41 years of age, weighting 165.3 lb, was diagnosed with systemic antiviral treatment and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: enanthema, hypersensitivity, lymphadenopathy, pharyngolaryngeal pain, pruritus, rash, rash maculo-papular, thirst. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with TRIZIVIR, COMBIVIR, VIRACEPT. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported TELZIR problem on Aug 11, 2006. Male patient, 41 years of age, weighting 165.3 lb, was diagnosed with systemic antiviral treatment and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: enanthema, hypersensitivity, lymphadenopathy, pharyngolaryngeal pain, pruritus, rash, rash maculo-papular, thirst. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with TRIZIVIR, COMBIVIR, VIRACEPT. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Physician from ITALY on May 02, 2006. Male patient, 33 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: anaemia, haemolytic anaemia, histiocytosis haematophagic. TELZIR dosage: 1400MG PER DAY. During the same period patient was treated with RITONAVIR, STAVUDINE, TENOFOVIR. Patient was hospitalized. Patient died on 09/01/2006.

Physician from FRANCE reported TELZIR problem on Oct 04, 2006. Male patient, 47 years of age, weighting 160.9 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: cholecystitis acute, hepatic steatosis, liver disorder, pain, umbilical hernia. TELZIR dosage: 700MG PER DAY. During the same period patient was treated with REYATAZ, NORVIR. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Physician from FRANCE on Oct 05, 2006. Female patient, 28 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, transaminases increased. TELZIR dosage: 700MG TWICE PER DAY. Patient recovered.

Physician from FRANCE reported TELZIR problem on Oct 05, 2006. Male patient, 42 years of age, weighting 151.0 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, transaminases increased. TELZIR dosage: 700MG TWICE PER DAY. Patient recovered.

TELZIR problem was reported by a Physician from FRANCE on Oct 05, 2006. Male patient, 25 years of age, weighting 147.7 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, hepatitis c, transaminases increased. TELZIR dosage: 700MG TWICE PER DAY. Patient recovered.

Physician from FRANCE reported TELZIR problem on Oct 04, 2006. Male patient, 47 years of age, weighting 160.9 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: cholecystitis acute, hepatic steatosis, pain, umbilical hernia. TELZIR dosage: 700MG PER DAY. During the same period patient was treated with REYATAZ, NORVIR. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Consumer or non-health professional from FRANCE on Oct 26, 2006. Male patient, 49 years of age, weighting 165.3 lb, was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: alopecia, blood alkaline phosphatase increased, chills, diarrhoea, gamma-glutamyltransferase increased, gingivitis, mucosal inflammation, neutropenia. TELZIR dosage: unknown. During the same period patient was treated with KALETRA, TAXOTERE, CEFUROXIME, FUZEON, EMTRIVA, ATARAX, ASPEGIC, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SPAIN reported TELZIR problem on Nov 14, 2006. Male patient, 39 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: hepatorenal syndrome, peritoneal infection, sepsis. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with TRUVADA, NORVIR, SEPTRA. Patient was hospitalized. Patient died on 09/27/2006.

TELZIR problem was reported by a Physician from FRANCE on Oct 04, 2006. Male patient, 47 years of age, weighting 160.9 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: cholecystitis acute, hepatic steatosis, pain, umbilical hernia. TELZIR dosage: 1400MG PER DAY. During the same period patient was treated with REYATAZ, NORVIR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported TELZIR problem on Nov 27, 2006. Male patient, 37 years of age, weighting 125.7 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: gastrointestinal disorder, pancreatitis. TELZIR dosage: unknown. During the same period patient was treated with NORVIR, VIREAD, EMTRIVA. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Consumer or non-health professional from FRANCE on Nov 29, 2006. Male patient, 48 years of age, was diagnosed with hiv infection, depression and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: abasia, atrial septal defect, blood lactic acid increased, cardiac aneurysm, coordination abnormal, extrapyramidal disorder, facial palsy, hypertriglyceridaemia, hypotension. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with ABACAVIR, NORVIR, SEROPLEX, TERCIAN. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported TELZIR problem on Oct 04, 2006. Male patient, 47 years of age, weighting 160.9 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: cholecystitis acute, hepatic steatosis, pain, umbilical hernia. TELZIR dosage: 1400MG PER DAY. During the same period patient was treated with REYATAZ, NORVIR. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Consumer or non-health professional from FRANCE on Nov 27, 2006. Male patient, 37 years of age, weighting 125.7 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: gastrointestinal disorder, pancreatitis. TELZIR dosage: unknown. During the same period patient was treated with NORVIR, VIREAD, EMTRIVA. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported TELZIR problem on Dec 15, 2006. Male patient, 27 years of age, weighting 154.3 lb, was diagnosed with hiv infection, hepatitis c and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, condition aggravated, epistaxis, haemoglobin decreased. TELZIR dosage: 1400MG PER DAY. During the same period patient was treated with NORVIR, REYATAZ, PEGASYS, RIBAVIRIN. Patient was hospitalized. Patient recovered.

TELZIR problem was reported by a Consumer or non-health professional from FRANCE on Dec 15, 2006. Male patient, 36 years of age, weighting 176.4 lb, was diagnosed with hiv infection, opportunistic infection prophylaxis and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood creatinine increased, cholecystitis, cytolytic hepatitis. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with NORVIR, TRUVADA, AZADOSE, ZELITREX, BACTRIM. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported TELZIR problem on Mar 30, 2006. Male patient, 29 years of age, weighting 176.4 lb, was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, erythema multiforme, off label use, oral soft tissue disorder, pruritus, rash maculo-papular, skin exfoliation. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with COMBIVIR, NORVIR. Patient recovered.

TELZIR problem was reported by a Consumer or non-health professional from FRANCE on Aug 08, 2007. Female patient, 45 years of age, weighting 121.3 lb, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: calculus urinary, cystitis haemorrhagic. TELZIR dosage: unknown. During the same period patient was treated with REYATAZ, EFFEXOR, LARGACTIL, NEURONTIN, CLONAZEPAM. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported TELZIR problem on Aug 16, 2007. Female patient was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: hydronephrosis, ultrasound antenatal screen abnormal. TELZIR dosage: 1400MG PER DAY. During the same period patient was treated with TRUVADA, NORVIR. Patient recovered.

TELZIR problem was reported by a Physician from COLOMBIA on Sept 12, 2007. Female patient, 41 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: arthralgia, chills, oedema, pruritus, pyrexia, rash papular. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with RITONAVIR, LAMIVUDINE. Patient recovered.

Consumer or non-health professional from FRANCE reported TELZIR problem on Sept 12, 2007. Male patient, 43 years of age, was diagnosed with hiv infection and was treated with TELZIR. After drug was administered, patient experienced the following problems/side effects: aphthous stomatitis, conjunctival haemorrhage, dyspepsia, oral mucosal blistering, oral mucosal eruption, purpura, rash, rash papular, viral infection. TELZIR dosage: 700MG TWICE PER DAY. During the same period patient was treated with REYATAZ, KIVEXA, NORVIR, PROZAC, KARDEGIC, ZOLPIDEM TARTRATE, ACETAMINOPHEN. Patient recovered.

back to top

New! Check out useful Hospital Quality Data! Click on a state to continue:

ALABAMA  ALASKA  AMERICAN SAMOA  ARIZONA  ARKANSAS  CALIFORNIA  COLORADO  CONNECTICUT  DELAWARE  DISTRICT OF COLUMBIA  FEDERATED STATES OF MICRONESIA  FLORIDA  GEORGIA  GUAM  HAWAII  IDAHO  ILLINOIS  INDIANA  IOWA  KANSAS  KENTUCKY  LOUISIANA  MAINE  MARSHALL ISLANDS  MARYLAND  MASSACHUSETTS  MICHIGAN  MINNESOTA  MISSISSIPPI  MISSOURI  MONTANA  NEBRASKA  NEVADA  NEW HAMPSHIRE  NEW JERSEY  NEW MEXICO  NEW YORK  NORTH CAROLINA  NORTH DAKOTA  NORTHERN MARIANA ISLANDS  OHIO  OKLAHOMA  OREGON  PALAU  PENNSYLVANIA  PUERTO RICO  RHODE ISLAND  SOUTH CAROLINA  SOUTH DAKOTA  TENNESSEE  TEXAS  UTAH  VERMONT  VIRGIN ISLANDS  VIRGINIA  WASHINGTON  WEST VIRGINIA  WISCONSIN  WYOMING back to top

Home Care Provider Quality Reports and Home Care Provider Reviews

ALABAMA  ALASKA  AMERICAN SAMOA  ARIZONA  ARKANSAS  CALIFORNIA  COLORADO  CONNECTICUT  DELAWARE  DISTRICT OF COLUMBIA  FEDERATED STATES OF MICRONESIA  FLORIDA  GEORGIA  GUAM  HAWAII  IDAHO  ILLINOIS  INDIANA  IOWA  KANSAS  KENTUCKY  LOUISIANA  MAINE  MARSHALL ISLANDS  MARYLAND  MASSACHUSETTS  MICHIGAN  MINNESOTA  MISSISSIPPI  MISSOURI  MONTANA  NEBRASKA  NEVADA  NEW HAMPSHIRE  NEW JERSEY  NEW MEXICO  NEW YORK  NORTH CAROLINA  NORTH DAKOTA  NORTHERN MARIANA ISLANDS  OHIO  OKLAHOMA  OREGON  PALAU  PENNSYLVANIA  PUERTO RICO  RHODE ISLAND  SOUTH CAROLINA  SOUTH DAKOTA  TENNESSEE  TEXAS  UTAH  VERMONT  VIRGIN ISLANDS  VIRGINIA  WASHINGTON  WEST VIRGINIA  WISCONSIN  WYOMING

back to top

Side Effects can be harmful to Your Health! Check adverse reaction reports for these medication and vaccine side effects:

back to top

Search for additional information about TELZIR here:
Thank you for visiting Patientsville.net. Hope you enjoyed finding information on TELZIR and found answers to TELZIR Questions